A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea
Stopped early · Phase 3
Conditions studied: Enterocolitis, Pseudomembranous, Diarrhea, Clostridium Difficile
In brief
Approximately 65 patients will be entered into this study taking place in North America. The aim of this study is to evaluate the safety, efficacy and absorption of an investigational drug in patients with C. difficile-associated diarrhea (CDAD). All study related care is provided including doctor visits, physical exams, laboratory tests and study medication. Total length of participation is 6 weeks.
Key facts
- Study ID
- NCT00466635
- Run by
- Genzyme, a Sanofi Company
- People needed
- 65
- Starts
- 2007-04-01
- Expected to finish
- 2007-08-01
- Last updated by the study team
- 2015-03-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The presence of CDAD at the time of enrollment
- Negative serum pregnancy test (HCG) for women of childbearing potential.
You may not qualify if…
- Any contraindication to oral / enteral therapy including fulminant C. difficile disease.
- Any acutely life-threatening medical conditions.
- Acute or chronic diarrhea of other cause.
Where it is running
- Study site — Modesto, California, United States
- Study site — Honolulu, Hawaii, United States
- Study site — Maywood, Illinois, United States
- Study site — Baltimore, Maryland, United States
- Study site — Worcester, Massachusetts, United States
- Study site — West Bloomfield, Michigan, United States
- Study site — Butte, Montana, United States
- Study site — Cedar Knolls, New Jersey, United States
- Study site — Neptune City, New Jersey, United States
- Study site — Syracuse, New York, United States
- Study site — Greenville, North Carolina, United States
- Study site — Toledo, Ohio, United States
- Study site — Lancaster, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.